D-0112-2017 Class II Terminated

Recalled by Supernus Pharmaceuticals, Inc. — Rockville, MD

FDA drug recall D-0112-2017 was initiated by Supernus Pharmaceuticals, Inc. on Jul 12, 2016 and is designated Class II. Reason for recall: Superpotent Drug: Failure of assay specifications in the capsule. The recall status is terminated (terminated Feb 26, 2019). Affected quantity: 17,128 (30-count blister packs).

Recall details

Product Type
Drugs
Report Date
Oct 26, 2016
Initiation Date
Jul 12, 2016
Termination Date
Feb 26, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17,128 (30-count blister packs)

Product description

Trokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850, NDC 17772-102-15

Reason for recall

Superpotent Drug: Failure of assay specifications in the capsule.

Distribution pattern

Nationwide

Code information

Lot # 426636, Exp 4/22/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0112-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0112-2017. Report a data issue: hello@regdatalab.com.